English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Peripheral lymphoid cells, from 3 cases of acute infectious mononucleosis (IM) and 2 cases of healthy individuals, were tested in a colony inhibition assay for cytotoxic activity against two cell lines that did or did not carry the Epstein-Barr virus (EBV) genome, A2L/AH and Ad cells respectively. T-lymphocyte fraction of IM was specifically cytotoxic for EBV-genome carrying cells and the residual lymphocyte fraction had high ADCC but low NK activity compared to the normal donors. When the A2L/AH cells which were forced to enter the EBV-cycle by n-butyrate treatment used as target cells, B-cell enriched fraction showed increased cytotoxic effect that was more remarkable in NK activity than ADCC in normal donors. These results were considered to be useful for possible specific immuno-therapy in nasopharyngeal carcinoma.

nippon jibi inkouka gakkai kaihou/nippon jibi inkoka gakkai kaiho

Cytotoxic effector cells specific for Epstein-Barr nuclear antigen positive nasopharyngeal hybrid cells are present in patients with infectious mononucleosis.